BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Affymax

Affymax, Inc. is a drug discovery powerhouse uniquely positioned to leverage over a decade of pharmaceutical drug discovery experience. As an industry pioneer with a five-year history working inside GlaxoSmithKline, one of the world’s largest pharmaceutical companies, Affymax has a proven track record of discovering promising drug leads for difficult pharmaceutical targets. Now, as an independent drug discovery company headquartered in Palo Alto, California, it is leveraging all of its rich heritage and assets to combine in one place proprietary technologies, a targeted systems-based approach, broad and deep scientific expertise and, most uniquely, a first-hand working knowledge of pharmaceutical drug development.


Contact Details:
4001 Miranda Avenue
Palo Alto
94304
United States of America
Tel:(650) 812-8700
Fax:(650) 424-0832
Email:info@affymax.com
WWW:

www.affymax.com/




Recent Publications by Affymax:

Designing better coumarin-based fluorogenic substrates for PTP1B.
As part of a program to develop better PTP1B fluorogenic substrates that...
10th July, 2008
Affymax, Inc., Department of Chemistry, 4001 Miranda Avenue, Palo Alto, CA Bioorg Med Chem Lett. 2008 Jun 1;18(11):3382-5. Epub 2008 Apr 13.
DOI Direct Link
Preclinical safety and pharmacology of Hematide, a peptidic erythropoiesis stimulating agent (ESA), in rats and monkeys.
The pharmacology, toxicokinetics, and safety of Hematide, a synthetic...
13th June, 2008
Affymax, Inc, Palo Alto, California 94304, USA. Drug Chem Toxicol. 2008;31(2):229-44.
DOI Direct Link
Chronic preclinical safety evaluation of Hematide, a pegylated peptidic erythropoiesis stimulating agent in monkeys.
Hematide is a synthetic peptide-based, pegylated erythropoiesis...
4th June, 2008
Affymax, Inc, 4001 Miranda Avenue, Palo Alto, CA 94304, USA. Haematologica. 2008 Sep;93(9):1376-9. Epub 2008 Jun 2.
DOI Direct Link
PTP1B inhibitors: synthesis and evaluation of difluoro-methylenephosphonate bioisosteres on a sulfonamide scaffold.
We have synthesized and evaluated a series of triaryl sulfonamide-based...
17th May, 2008
Affymax, Inc., 4001 Miranda Avenue, Palo Alto, CA 94304, USA. Bioorg Med Chem Lett. 2008 Apr 15;18(8):2719-24. Epub 2008 Mar 6.
DOI Direct Link
Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
OBJECTIVE: To evaluate the potential of Hematide, a PEGylated, synthetic...
19th September, 2007
Affymax, Inc, Palo Exp Hematol. 2007 Aug;35(8):1201-8.
DOI Direct Link

View more Affymax research publications.

BioNews Results for Affymax:

Affymax to Present at UBS Global Life Sciences Conference
Pharma Live:  Sep 18 2008 9:15AM Matching: affymax
Affymax to Present at UBS Global Life Sciences Conference
DiGiTAL50:  Sep 17 2008 6:37PM Matching: affymax
Analysts upbeat about Affymax after it narrows its drug focus
East Bay Business Journal:  Sep 8 2008 4:46AM Matching: affymax
Analysts upbeat about Affymax after it narrows its drug focus
Biz Journals:  Sep 8 2008 5:08AM Matching: affymax
Affymax, Takeda Nix Hematide After FDA and CMS Decisions
Therapeutics Daily:  Sep 8 2008 10:19PM Matching: affymax
Promote your company here: BioNewsCast - Press Release Distribution

View more Affymax news.

Affymax Patents:

US Patent No.Title
5679773 Reagants and methods for immobilized polymer synthesis and display
5811238 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
5814603 Compounds with PTH activity
5817751 Method for synthesis of diketopiperazine and diketomorpholine derivatives
5830721 DNA mutagenesis by random fragmentation and reassembly

View more Affymax patents.

Affymax (AFFY) Financial information Links from Barchart

AFFY Quote from from Barchart.com
AFFY Chart from from Barchart.com
AFFY Profile from from Barchart.com
AFFY Opinion from from Barchart.com

View more Affymax finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 29 individuals from Affymax using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 549 times since April 2007, the link to the organisation's website has been followed 90 times

Recent Search Terms used to find this page: @Affymax .com AND email | AFFYMAX | AFFYMAX HEMATIDE UK | affymax history | affymax email | affymax | Affymax Technologies | t | affymax history | affymax us patent | .

Search for more companies in Palo Alto

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Affymax
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.